Education
About Us
Working with TipRanks
Follow Us
Neural Therapeutics Inc. (TSE:NURL)
:NURL
NURL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.05
Previous CloseN/A
VolumeN/A
Average Volume (3M)294.01K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.14
Next Earnings
Jun 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding80,611,220
10 Day Avg. Volume506,609
30 Day Avg. Volume294,010
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neural Therapeutics Inc. News
NURL FAQ
What was Neural Therapeutics Inc.’s price range in the past 12 months?
Neural Therapeutics Inc. lowest stock price was C$0.01 and its highest was C$0.05 in the past 12 months.
What is Neural Therapeutics Inc.’s market cap?
Currently, no data Available
When is Neural Therapeutics Inc.’s upcoming earnings report date?
Neural Therapeutics Inc.’s upcoming earnings report date is Jun 27, 2025 which is 91 days ago.
How were Neural Therapeutics Inc.’s earnings last quarter?
Currently, no data Available
Is Neural Therapeutics Inc. overvalued?
According to Wall Street analysts Neural Therapeutics Inc.’s price is currently Overvalued.
Does Neural Therapeutics Inc. pay dividends?
Neural Therapeutics Inc. does not currently pay dividends.
What is Neural Therapeutics Inc.’s EPS estimate?
Neural Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neural Therapeutics Inc. have?
Neural Therapeutics Inc. has 80,611,220 shares outstanding.
What happened to Neural Therapeutics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Neural Therapeutics Inc.?
Currently, no hedge funds are holding shares in TSE:NURL
Company Description
Neural Therapeutics Inc.
Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company's innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.
Technical Analysis
Wesana Health Holdings Inc
―
Braxia Scientific
―
HAVN Life Sciences
―
MYND Life Sciences
―
Lexston Life Sciences Corp.
―